Discovery of selective probes and antagonists for G protein-coupled receptors FPR/FPRL1 and GPR30

Current Topics in Medicinal Chemistry

Volumn 9, Issue 13, 2009, Pages 1227-1236

  Arterburn, Jeffrey B ^a,d   Oprea, Tudor I ^b,d   Prossnitz, Eric R ^c,d   Edwards, Bruce S ^c,e   Sklar, Larry A ^c,d  

^a NEW MEXICO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Antidepressant; Cancer; Estrogen; Flow cytometry; Fluorescent; Formylpeptide receptor; GPCR; GPER; GPR30; Inflammation; Nongenomic

Indexed keywords

17ALPHA ESTRADIOL; ESTRADIOL; ESTROGEN RECEPTOR; FLUORESCENT DYE; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; CHEMICAL STRUCTURE; FLOW CYTOMETRY; INFORMATION SCIENCE; MOLECULAR PROBE; NONHUMAN; REVIEW; SYNTHESIS; VIRTUAL REALITY;

DRUG DISCOVERY; FLUORESCENT DYES; MOLECULAR PROBES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 74249084687     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802609789753608     Document Type: Review

References (60)

1. Sklar, L. A.; Carter, M. B.; Edwards, B. S. Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. Curr. Opin. Pharmacol. 2007, 7, 527-34.
2. Edwards, B. S.; Oprea, T. I.; Prossnitz, E. R.; Sklar, L. A. Flow cytometry for high-throughput, high-content screening. Curr. Opin. Chem. Biol. 2004, 8, 392-8.
3. Nolan, J. P.; Sklar, L. A. The emergence of flow cytometry for sensitive, real-time measurements of molecular interactions. Nat. Biotechnol. 1998, 16, 633-8.
4. Sklar, L. A.; Edwards, B. S.; Graves, S. W.; Nolan, J. P.; Prossnitz, E. R. Flow cytometric analysis of ligand-receptor interactions and molecular assemblies. Annu. Rev. Biophys. Biomol. Struct. 2002, 31, 97-119.
5. Ramirez, S.; Aiken, C. T.; Andrzejewski, B.; Sklar, L. A.; Edwards, B. S. High-throughput flow cytometry: validation in microvolume bioassays. Cytometry. A 2003, 53, 55-65.
6. Kuckuck, F. W.; Edwards, B. S.; Sklar, L.A. High throughput flow cytometry. Cytometry 2001, 44, 83-90.
7. Edwards, B. S.; Young, S. M.; Ivnitsky-Steele, I.; Ye, R. D.; Prossnitz, E. R.; Sklar, L. A. High-content screening: flow cytometry analysis. Methods Mol. Biol. 2009, 486, 151-65.
8. Ye, R. D.; Boulay, F.; Wang, J.M.; Dahlgren, C.; Gerard, C.; Parmentier, M.; Serhan, C. N.; Murphy, P. M. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009, 61, 119-61.
9. Panaro, M. A.; Acquafredda, A.; Sisto, M.; Lisi, S.; Maffione, A. B.; Mitolo, V. Biological role of the N-formyl peptide receptors. Immunopharmacol. Immunotoxicol. 2006, 28, 103-27.
10. Blakeney, J. S.; Fairlie, D. P. Nonpeptide ligands that target peptide-activated GPCRs in inflammation. Curr. Med. Chem. 2005, 12, 3027-42.
11. Dalpiaz, A.; Scatturin, A. Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils. Mini Rev. Med. Chem. 2003, 3, 167-73.
12. Edwards, B. S.; Bologa, C.; Young, S. M.; Balakin, K. V.; Prossnitz, E. R.; Savchuck, N. P.; Sklar, L. A.; Oprea, T. I. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists. Mol. Pharmacol. 2005, 68, 1301-10.
13. Zhou, C.; Zhang, S.; Nanamori, M.; Zhang, Y.; Liu, Q.; Li, N.; Sun, M.; Tian, J.; Ye, P. P.; Cheng, N.; Ye, R. D.; Wang, M. W. Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1. Mol. Pharmacol. 2007, 72, 976-83.
14. Edwards, B. S.; Young, S. M.; Oprea, T. I.; Bologa, C. G.; Prossnitz, E. R.; Sklar, L. A. Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform. Nat. Protoc. 2006, 1, 59-66.
15. Baek, S. H.; Seo, J. K.; Chae, C. B.; Suh, P. G.; Ryu, S. H. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J. Biol. Chem. 1996 271, 8170-5.
16. Bae, Y. S.; Song, J. Y.; Kim, Y.; He, R.; Ye, R. D.; Kwak, J. Y.; Suh, P. G.; Ryu, S. H. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol. Pharmacol. 2003 64, 841-7.
17. Strouse, J. J.; Young, S. M.; Mitchell, H. D.; Ye, R. D.; Prossnitz, E. R.; Sklar, L. A.; Edwards, B. S. A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand. Cytometry A 2009, 75, 264-70.
18. Wan, H. X.; Zhou, C.; Zhang, Y.; Sun, M.; Wang, X.; Yu, H.; Yang, X.; Ye, R. D.; Shen, J. K.; Wang, M. W. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1. Biochem. Pharmacol. 2007, 74, 317-26.
19. Ramirez, S.; Aiken, C. T.; Andrzejewski, B.; Sklar, L. A.; Edwards, B. S. High-throughput flow cytometry: validation in microvolume bioassays. Cytometry A 2003, 53, 55-65.
20. Young, S. M.; Bologa, C. M.; Fara, D.; Bryant, B. K.; Strouse, J. J.; Arterburn, J. B.; Ye, R. D.; Oprea, T. I.; Prossnitz, E. R.; Sklar, L. A.; Edwards, B. S. Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes. Cytometry A 2009, 75, 253-63.
21. Filardo, E. J.; Quinn, J. A.; Sabo, E. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids 2008, 73, 870-3.
22. Prossnitz, E. R.; Arterburn, J. B.; Smith, H. O.; Oprea, T. I.; Sklar, L. A.; Hathaway, H. J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70, 165-90.
23. Raz, L.; Khan, M. M.; Mahesh, V. B.; Vadlamudi, R. K.; Brann, D. W. Rapid estrogen signaling in the brain. Neurosignals 2008, 16, 140-53.
24. Watson, C. S.; Alyea, R. A.; Jeng, Y. J.; Kochukov, M. Y. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol. Cell. Endocrinol. 2007, 274, 1-7.
25. Thomas, P.; Dressing, G.; Pang, Y.; Berg, H.; Tubbs, C.; Benninghoff, A.; Doughty, K. Progestin, estrogen and androgen G-protein coupled receptors in fish gonads. Steroids 2006, 71, 310-6.
26. Filardo, E. J.; Thomas, P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab. 2005, 16, 362-7.
27. Thomas, P.; Pang, Y.; Filardo, E. J.; Dong, J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146, 624-32.
28. Revankar, C. M.; Cimino, D. F.; Sklar, L. A.; Arterburn, J. B.; Prossnitz, E. R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307, 1625-30.
29. Filardo, E. J.; Graeber, C. T.; Quinn, J. A.; Resnick, M. B.; Giri, D.; DeLellis, R. A.; Steinhoff, M. M.; Sabo, E. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin. Cancer Res. 2006, 12, 6359-66.
30. Smith, H. O.; Leslie, K. K.; Singh, M.; Qualls, C. R.; Revankar, C. M.; Joste, N. E.; Prossnitz, E. R. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 2007, 196, 386 e1-11.
31. Smith, H. O.; Arias-Pulido, H.; Kuo, D. Y.; Howard, T.; Qualls, C. R.; Lee, S. J.; Verschraegen, C. F.; Hathaway, H. J.; Joste, N. E.; Prossnitz, E. R. GPR30 predicts poor survival for ovarian cancer. Gynecol. Oncol. 2009, 114(3), 465-471.
32. Prossnitz, E. R.; Sklar, L. A.; Oprea, T. I.; Arterburn, J. B. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol. Sci. 2008, 29, 116-23.
33. Boivin, B.; Vaniotis, G.; Allen, B. G.; Hébert, T. E. G protein-coupled receptors in and on the cell nucleus: a new signaling paradigm? J. Recept. Signal. Transduct. Res. 2008, 28, 15-28.
34. Goetzl, E. J. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. FASEB J. 2007, 21, 638-42.
35. Hanyaloglu, A. C.; von Zastrow, M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu. Rev. Pharmacol. Toxicol. 2008, 48, 537-68.
36. Gobeil, F.; Fortier, A.; Zhu, T.; Bossolasco, M.; Leduc, M.; Grandbois, M.; Heveker, N.; Bkaily, G.; Chemtob, S.; Barbaz, D. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can. J. Physiol. Pharmacol. 2006, 84, 287-97.
37. Zhu. T.; Gobeil, F.; Vazquez-Tello, A.; Leduc, M.; Rihakova, L.; Bossolasco, M.; Bkaily, G.; Peri, K.; Varma, D. R.; Orvoine, R.; Chemtob, S. Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. Can. J. Physiol. Pharmacol. 2006, 84, 377-91.
38. Marrache, A. M.; Gobeil, F.; Zhu, T.; Chemtob, S. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. Endothelium 2005, 12, 63-72.
39. Lo, H. W.; Hung, M. C. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br. J. Cancer 2006, 94, 184-8.
40. Revankar, C. M.; Mitchell, H. D.; Field, A. S.; Burai, R.; Corona, C.; Ramesh, C.; Sklar, L. A.; Arterburn, J. B.; Prossnitz, E. R. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2007, 2, 536-44.
41. Stevis, P. E.; Deecher, D. C.; Suhadolnik, L.; Mallis, L. M.; Frail, D. E. Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 1999, 140, 5455-8.
42. Harrington, W. R.; Kim, S. H.; Funk, C. C.; Madak-Erdogan, Z.; Schiff, R.; Katzenellenbogen, J. A.; Katzenellenbogen, B. S. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol. Endocrinol. 2006, 20, 491-502.
43. Kim, S. H.; Katzenellenbogen, J. A. Hormone-PAMAM dendrimer conjugates: polymer dynamics and tether structure affect ligand access to receptors. Angew. Chem. Int. Ed. Engl. 2006, 45, 7243-8.
44. Savchuk, N. P.; Tkachenko, S. E.; Balakin, K. V. Rational Design of GPCR-specific combinational libraries based on the concept of privileged substructures. In: Chemoinformatics in Drug Discovery: Oprea, T.I.: Ed. Wiley VCH, Weinheim, 2005, pp. 287-313.
45. Bologa, C. G.; Revankar, C. M.; Young, S. M.; Edwards, B. S.; Arterburn, J. B.; Kiselyov, A. S.; Parker, M. A.; Tkachenko, S. E.; Savchuck, N. P.; Sklar, L. A.; Oprea, T. I.; Prossnitz, E. R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006, 2, 207-212.
46. Noel, S. D.; Keen, K. L.; Baumann, D. I.; Filardo, E. J.; Terasawa, E. Involvement of G-Protein Coupled Receptor 30 (GPR30) in Rapid Action of Estrogen in Primate LHRH Neurons. Mol. Endocrinol. 2009, 23, 349-59.
47. Brailoiu, E.; Dun, S. L.; Brailoiu, G. C.; Mizuo, K.; Sklar, L. A.; Oprea, T. I.; Prossnitz, E. R.; Dun, N. J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193, 311-321.
48. Dun, S. L.; Brailoiu, G. C.; Gao, X.; Brailoiu, E.; Arterburn, J. B.; Prossnitz, E. R.; Oprea, T. I.; Dun, N. J. Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia. J. Neurosci. Res. 2009, 87, 1610-9.
49. Kuhn, J.; Dina, O. A.; Goswami, C.; Suckow, V.; Levine, J. D.; Hucho, T. GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat. Eur. J. Neurosci. 2008, 27, 1700-9.
50. Albanito, L.; Madeo, A.; Lappano, R.; Vivacqua, A.; Rago, V.; Carpino, A.; Oprea, T. I.; Prossnitz, E. R.; Musti, A. M.; Andò, S.; Maggiolini, M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67, 1859-1866.
51. Pandey, D. P.; Lappano, R.; Albanito, L.; Madeo, A.; Maggiolini, M.; Picard, D. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28, 523-32.
52. Teng, J.; Wang, Z.Y.; Prossnitz, E.R.; Bjorling, D.E. The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinology 2008, 149, 4024-4034.
53. Pang, Y.; Dong, J.; Thomas, P. Estrogen signaling characteristics of Atlantic croaker G protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology 2008, 149, 3410-3426.
54. Wang, C.; Prossnitz, E. R.; Roy, S. K. G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 2008, 149, 4452-4461.
55. Wang, C.; Dehghani, B.; Magrisso, I. J.; Rick, E. A.; Bonhomme, E.; Cody, D. B.; Elenich, L. A.; Subramanian, S.; Murphy, S. J.; Kelly, M. J.; Rosenbaum, J. S.; Vandenbark, A. A.; Offner, H. GPR30 contributes to estrogen-induced thymic atrophy. Mol. Endocrinol. 2008, 22, 636-648.
56. Wang, C.; Dehghani, B.; Li, Y.; Kaler, L. J.; Proctor, T.; Vandenbark, A. A.; Offner, H. Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J. Immunol. 2009, 182, 3294-3303.
57. Haas, E.; Bhattacharya, I.; Brailoiu, E.; Damjanović, M.; Brailoiu, G. C.; Gao, X.; Mueller-Guerre, L.; Marjon, N. A.; Gut, A.; Minotti, R.; Meyer, M. R.; Amann, K.; Ammann, E.; Perez-Dominguez, A.; Genoni, M.; Clegg, D. J.; Dun, N. J.; Resta, T. C.; Prossnitz, E. R.; Barton, M. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ. Res. 2009, 104, 288-91.
58. Otto, C.; Rohde-Schulz, B.; Schwarz, G.; Fuchs, I.; Klewer, M.; Brittain, D.; Langer, G.; Bader, B.; Prelle, K.; Nubbemeyer, R.; Fritzemeier, K. H. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 2008, 149, 4846-56.
59. Dennis, M. K.; Burai, R.; Ramesh, C.; Petrie, W. K.; Alcon, S. N.; Nayak, T. K.; Bologa, C. G.; Leitao, A.; Brailoiu, E.; Deliu, E.; Dun, N. J.; Sklar, L. A.; Hathaway, H. J.; Arterburn, J. B.; Oprea, T. I.; Prossnitz, E. R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009, 5, 421-7.
60. Oprea T. I.; Bologa C. G.; Boyer, S.; Curpan, R. F.; Glen, R.C.; Hopkins, A. L.; Lipinski, C. A.; Marshall, G. R., Martin, Y. C.; Ostopovici-Halip, L.; Rishton, G.; Shoichet, B. K.; Ursu, O.; Vaz, R. J.; Waller, C. L.; Waldmann, H.; Sklar. L. A. A crowdsourcing evaluation of the NIH chemical probes. Nat. Chem. Biol. 2009, 5, 441-447.